Back to products
Sustanon 250
Injectables

Sustanon 250

Sustanon 250 is a blend of four testosterone esters, designed to provide both immediate and prolonged release of testosterone into the bloodstream.

  • Sustanon 250 is a multi-ester formulation of testosterone, containing testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate.
  • This strategic blend is designed to deliver both fast-acting and long-lasting testosterone effects, maintaining stable hormone levels over an extended period.
  • The propionate and phenylpropionate esters provide a rapid initial release, while the isocaproate and decanoate esters ensure sustained release over several weeks.

Product overview

Sustanon 250 is a multi-ester formulation of testosterone, containing testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. This strategic blend is designed to deliver both fast-acting and long-lasting testosterone effects, maintaining stable hormone levels over an extended period.

Studied in research on androgen signaling, anabolic response, and serum hormone profiling.

Every batch is independently tested at two accredited third-party laboratories. Each shipment is accompanied by a batch-specific Certificate of Analysis. Material Safety Data Sheets (MSDS) and Laboratory Chemical Safety Summaries (LCSS) are available on request.

Research use

Studied in research on androgen signaling, anabolic response, and serum hormone profiling.

Storage

Store at 15–25 °C (59–77 °F), protected from light and moisture. Do not freeze.

Presentation

Sterile oil-based solution in a sealed multi-dose vial with carton and insert.

Quality assurance

Independently verified at two accredited third-party laboratories. Batch-specific COA included with every shipment.

Research use only. All EBIOM products are supplied strictly for laboratory and preclinical research. They are not intended for human or veterinary use, diagnosis, or treatment of any medical condition. Handling must comply with all applicable laws and institutional safety guidelines.